CHARLES RIVER LABORATORIES EDINBURGH LIMITED
Get an alert when CHARLES RIVER LABORATORIES EDINBURGH LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£952K
-32.2% lowest in 3 filed years
Net assets
£89M
+8.2% highest in 3 filed years
Employees
1,236
-9.1% lowest in 3 filed years
Profit before tax
£22M
-24.2% lowest in 3 filed years
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-27
| Metric | Trend | 2023-12-30 | 2024-12-28 | 2025-12-27 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £147,065,000 | £135,388,000 | £127,949,000 | -5.5% | |
| Operating profit | £37,507,000 | £27,706,000 | £21,894,000 | -21% | |
| Profit before tax | £39,054,000 | £29,067,000 | £22,035,000 | -24.2% | |
| Net profit | £29,240,000 | £21,955,000 | £16,595,000 | -24.4% | |
| Cash | £7,889,000 | £1,405,000 | £952,000 | -32.2% | |
| Total assets less current liabilities | — | — | — | — | |
| Net assets | £88,117,000 | £82,444,000 | £89,227,000 | +8.2% | |
| Equity | £88,117,000 | £82,444,000 | £89,227,000 | +8.2% | |
| Average employees | 1,377 | 1,359 | 1,236 | -9.1% | |
| Wages | £51,214,000 | £51,704,000 | £51,483,000 | -0.4% | |
| Directors' remuneration | £459,000 | £540,000 | £766,000 | +41.9% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-30 | 2024-12-28 | 2025-12-27 |
|---|---|---|---|---|
| Operating margin | 25.5% | 20.5% | 17.1% | |
| Net margin | 19.9% | 16.2% | 13.0% | |
| Gearing (liabilities / total assets) | — | 44.0% | 43.3% | |
| Current ratio | 1.27x | 1.25x | 1.29x | |
| Interest cover | — | — | 93.17x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 3 times since incorporation
- CHARLES RIVER LABORATORIES EDINBURGH LIMITED 2015-06-10 → present
- CHARLES RIVER LABORATORIES PRECLINICAL SERVICES EDINBURGH LTD. 2005-09-27 → 2015-06-10
- INVERESK RESEARCH INTERNATIONAL LIMITED 1985-12-31 → 2005-09-27
- JANODENE LIMITED 1985-02-18 → 1985-12-31
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on all of the available evidence, the directors have considered the intent and ability of Charles River Laboratories International, Inc. to provide financial support as required, noting no issues, and consequently have a reasonable expectation that the Company has adequate financial resources to continue in existence for the foreseeable future. In conclusion, they continue to adopt the going concern basis in preparing these financial statements.”
Significant events
- “Following the year-end, the Company acquired an additional leasehold property in order to expand its service offering. It is estimated that the property will be brought into use in the fourth quarter of 2026. Overall expenditure including refurbishment, and operational readiness is estimated to be approximately £8.7 million, an will be paid from existing cash resources.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 27 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HENEGHAN, Rushna Tejani | Secretary | 2021-01-01 | — | — |
| BATHGATE, Brian, Dr | Director | 2005-10-25 | Sep 1959 | British |
| BURNS, Geoffrey | Director | 2024-01-10 | Jun 1963 | British |
| HENEGHAN, Rushna Tejani | Director | 2021-01-01 | Jun 1963 | American |
Show 27 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| COWAN, Desmond Joseph Paul Edward | Secretary | 2004-04-16 | 2004-10-20 |
| DAVIDSON, Doreen | Secretary | 1990-03-31 | 2004-10-20 |
| JOHST, David | Secretary | 2004-10-20 | 2020-05-20 |
| LESLIE, Stewart Gordon | Secretary | 1993-10-13 | 1993-10-13 |
| PRICE, Sarah Margaret | Secretary | 2020-05-20 | 2020-12-31 |
| THOMSON, Leonard | Secretary | — | 1990-03-31 |
| ACKERMAN, Thomas | Director | 2004-10-20 | 2015-05-15 |
| BATHGATE, Brian, Dr | Director | 1997-01-22 | 2004-10-20 |
| CASSELS, Alexander | Director | 1988-11-30 | 1989-06-28 |
| COWAN, Desmond Joseph Paul Edward | Director | 2003-07-23 | 2004-10-20 |
| CURRIE, Alastair, Sir | Director | — | 1989-06-28 |
| DRAFFAN, George Harry, Dr | Director | — | 1989-06-28 |
| FOSTER, James | Director | 2004-10-20 | 2015-05-15 |
| JOHST, David | Director | 2004-10-20 | 2020-05-20 |
| LESLIE, Stewart Gordon | Director | 1993-10-13 | 2004-04-16 |
| MAIN, Peter Tester | Director | — | 1989-06-28 |
| MOLHO, Davide | Director | 2015-05-15 | 2018-08-02 |
| NEWMAN, Henry Bernard | Director | — | 1999-09-20 |
| NIMMO, Walter Sneddon, Dr | Director | 1997-01-22 | 2004-10-20 |
| PRICE, Sarah Margaret | Director | 2020-05-20 | 2020-12-31 |
| ROMOLI, Andrea | Director | 2022-06-06 | 2023-06-02 |
| SCHAAD, Peter | Director | — | 1991-06-01 |
| SMITH, David Ross | Director | 2015-05-15 | 2022-06-06 |
| SWORD, Ian Pollock, Doctor | Director | — | 2004-05-04 |
| THOMSON, Leonard | Director | — | 1993-08-23 |
| WILSON, Alexander Biggart | Director | — | 1989-06-28 |
| WISEMAN, Herbert Colin | Director | — | 1996-08-02 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Charles River Laboratories International Inc. | Corporate entity | Significant influence | 2017-06-28 | Active |
Filing timeline
Last 20 of 190 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-30 | AA | accounts | Accounts with accounts type full | |
| 2025-09-09 | AA | accounts | Accounts with accounts type full | |
| 2025-07-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-19 | AA | accounts | Accounts with accounts type full | |
| 2024-01-10 | AP01 | officers | Appoint person director company with name date | |
| 2023-08-23 | AA | accounts | Accounts with accounts type full | |
| 2023-07-24 | TM01 | officers | Termination director company with name termination date | |
| 2023-06-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-08-05 | AA | accounts | Accounts with accounts type full | |
| 2022-08-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-06-23 | AP01 | officers | Appoint person director company with name date | |
| 2022-06-23 | TM01 | officers | Termination director company with name termination date | |
| 2021-08-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-06-30 | AA | accounts | Accounts with accounts type full | |
| 2021-06-23 | AP01 | officers | Appoint person director company with name date | |
| 2021-06-23 | AP03 | officers | Appoint person secretary company with name date | |
| 2021-06-23 | TM01 | officers | Termination director company with name termination date | |
| 2021-06-23 | TM02 | officers | Termination secretary company with name termination date | |
| 2020-09-02 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.